Search research articles
Contact Us
Filters
Showing results (111-120 of 115) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 115 results.
Epilepsia
|
June 12, 2019
Direct and indirect costs associated with stereotactic radiosurgery or open surgery for medial temporal lobe epilepsy: Results from the ROSE trial
John T Langfitt, Mark Quigg, Guofen Yan, et al.
Epilepsia
|
March 31, 2018
Radiosurgery versus open surgery for mesial temporal lobe epilepsy: The randomized, controlled ROSE trial
Nicholas M Barbaro, Mark Quigg, Mariann M Ward, et al.
Seizure
|
November 9, 2018
Visual field defects after radiosurgery versus temporal lobectomy for mesial temporal lobe epilepsy: Findings of the ROSE trial
Mark Quigg, Nicholas M Barbaro, Mariann M Ward, et al.
Journal of Clinical Medicine
|
November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial
Michael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
International Forum of Allergy & Rhinology
|
September 7, 2022
International Consensus Statement on Obstructive Sleep Apnea
Jolie L Chang, Andrew N Goldberg, Jeremiah A Alt, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 115) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 115 results.
Epilepsia
|
June 12, 2019
Direct and indirect costs associated with stereotactic radiosurgery or open surgery for medial temporal lobe epilepsy: Results from the ROSE trial
John T Langfitt, Mark Quigg, Guofen Yan, et al.
Epilepsia
|
March 31, 2018
Radiosurgery versus open surgery for mesial temporal lobe epilepsy: The randomized, controlled ROSE trial
Nicholas M Barbaro, Mark Quigg, Mariann M Ward, et al.
Seizure
|
November 9, 2018
Visual field defects after radiosurgery versus temporal lobectomy for mesial temporal lobe epilepsy: Findings of the ROSE trial
Mark Quigg, Nicholas M Barbaro, Mariann M Ward, et al.
Journal of Clinical Medicine
|
November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial
Michael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
International Forum of Allergy & Rhinology
|
September 7, 2022
International Consensus Statement on Obstructive Sleep Apnea
Jolie L Chang, Andrew N Goldberg, Jeremiah A Alt, et al.
Page
of 12